Earlier today we announced the exciting news that the EMA has recommended that a licence should be granted for siponimod (Mayzent) for the treatment of active secondary progressive MS (SPMS). This video explains more about what siponimod is and how it works. Find out more at https://www.mstrust.org.uk/a-z/siponimod. | Multiple Sclerosis Trust

Jenny, 67, has been living with secondary progressive MS (SPMS) for more than a decade. Jenny talks about how she’s adapted to using a wheelchair, accepting assistance from carers and finding purpose through painting. 🎨 Read more about Jenny’s story 👉 https://mssoc.uk/3PNCsO7 | MS Society UK

Jasmine lives with secondary progressive MS (SPMS) at just 24. This is her story. "Having advanced MS affects everything... It’s made me feel absolutely alone at times. This is why I want to put my story out there." 💬 Jasmine tells us about her experience with assisted living, personal care and maintaining independence. Read more about Jasmine’s experience ➡️ https://mssoc.uk/3WfQYlC [Note: We know that everyone is affected by MS differently and we want everyone’s stories to be heard. If you li